NAGS antibody (AA 295-534)
Quick Overview for NAGS antibody (AA 295-534) (ABIN6144346)
Target
See all NAGS AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 295-534
-
Sequence
- NTGGLRDSSH KVLSNVNLPA DLDLVCNAEW VSTKERQQMR LIVDVLSRLP HHSSAVITAA STLLTELFSN KGSGTLFKNA ERMLRVRSLD KLDQGRLVDL VNASFGKKLR DDYLASLRPR LHSIYVSEGY NAAAILTMEP VLGGTPYLDK FVVSSSRQGQ GSGQMLWECL RRDLQTLFWR SRVTNPINPW YFKHSDGSFS NKQWIFFWFG LADIRDSYEL VNHAKGLPDS FHKPASDPGS
-
Cross-Reactivity
- Human, Mouse, Rat
-
Characteristics
- Polyclonal Antibodies
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 295-534 of human NAGS (NP_694551.1).
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB,1:500 - 1:1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- NAGS (N-Acetylglutamate Synthase (NAGS))
-
Alternative Name
- NAGS
-
Background
- The N-acetylglutamate synthase gene encodes a mitochondrial enzyme that catalyzes the formation of N-acetylglutamate (NAG) from glutamate and acetyl coenzyme-A. NAG is a cofactor of carbamyl phosphate synthetase I (CPSI), the first enzyme of the urea cycle in mammals. This gene may regulate ureagenesis by altering NAG availability and, thereby, CPSI activity. Deficiencies in N-acetylglutamate synthase have been associated with hyperammonemia.,NAGS,AGAS,ARGA,Cancer,Signal Transduction,Endocrine & Metabolism,Mitochondrial metabolism,Mitochondrial markers,Amino acid metabolism,NAGS
-
Molecular Weight
- 58 kDa
-
Gene ID
- 162417
-
UniProt
- Q8N159
Target
-